Detalhe da pesquisa
1.
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
PLoS Pathog
; 18(11): e1010945, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36395347
2.
The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine.
Res Sq
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746176
3.
A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice.
iScience
; 27(5): 109719, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706848
4.
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19.
Life Sci Alliance
; 6(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699657
5.
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual.
iScience
; 26(10): 108009, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841584
6.
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
Cell Rep Med
; 4(4): 101003, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37044090
7.
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual.
bioRxiv
; 2022 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263063
8.
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.
Cell Host Microbe
; 30(12): 1759-1772.e12, 2022 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400021
9.
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein.
Nat Commun
; 13(1): 4515, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922441
10.
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.
Nat Commun
; 13(1): 4539, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927266
11.
Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection.
Vaccines (Basel)
; 9(12)2021 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34960222
12.
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.
NPJ Vaccines
; 6(1): 24, 2021 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563983
13.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.
Elife
; 102021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34812143
14.
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nat Commun
; 12(1): 6097, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671037
15.
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Science
; 369(6504): 643-650, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540902
16.
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle.
Nat Commun
; 10(1): 4272, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537780